Product
Comirnaty(BTN162b2)
1 clinical trial
3 indications
Indication
Vaccine ReactionIndication
COVID-19Indication
VaccinationClinical trial
A Multinational, Phase 2, Randomised, Adaptive Protocol to Evaluate Immunogenicity and Reactogenicity of Different COVID-19 Vaccines Administration in Older Adults (≥75) Already Vaccinated Against SARS-COV-2 (EU-COVAT-1_AGED)Status: Completed, Estimated PCD: 2022-10-01